Lilly Buys Vaccine Makers
Eli Lilly acquires three vaccine developers to expand its portfolio. The deal is worth $3.8 billion.
Eli Lilly acquires three vaccine developers to expand its portfolio.
The deal is worth $3.8 billion.
Eli Lilly acquires three vaccine developers to expand its portfolio. The deal is worth $3.8 billion.
Eli Lilly acquires three vaccine developers to expand its portfolio.
The deal is worth $3.8 billion.